Chlorhexidine Gluconate Wipes Market Driven by Growing Coronavirus Pandemic

In 2022, the global market for chlorhexidine gluconate wipes was estimated to be worth USD 0.1 billion. The Chlorhexidine Gluconate Wipes Market is expected to increase from USD 0.11 billion in 2023 to USD 0.15 billion by 2032, with a compound yearly growth rate (CAGR) of 4.78% over the forecast period (2023-2032). The report presents a detailed overview of the global chlorhexidine gluconate wipes market, including an analysis of the market’s major drivers and restraints, key players, and other factors affecting the market’s movement. The impact of the COVID-19 pandemic on the global chlorhexidine gluconate wipes market is also assessed in the report.

The Chlorhexidine Gluconate Wipes market is thriving, driven by the growing emphasis on infection prevention in healthcare settings. CHG bath wipes offer a convenient and effective solution for patient hygiene and preoperative skin preparation. With increasing awareness of the importance of hygiene, the market for CHG wipes is expected to see sustained growth.

The Chlorhexidine Gluconate Wipes market is thriving, particularly in surgical settings, where hygiene is paramount. Chlorhexidine wipes are widely utilized for preoperative skin preparation to reduce the risk of surgical site infections. With healthcare facilities prioritizing infection control measures, the demand for chlorhexidine wipes for surgery is projected to grow steadily, ensuring patient safety.

Chlorhexidine gluconate wipes are antiseptic wipes used to avoid infection at healthcare sites such as hospitals. Chlorhexidine gluconate wipes are infused with chlorhexidine gluconate, which kills bacteria and other microbes and thus prevents infection. The rising prevalence of hospital-acquired infections is likely to be a major driver for the global chlorhexidine gluconate wipes market over the forecast period. Rising awareness about hospital-acquired infections has resulted in hospitals taking care to eliminate the chances of infections. This has resulted in a growing demand for chlorhexidine gluconate wipes over the last few years. Growing awareness about hospital-acquired infections is likely to be a major driver for the global chlorhexidine gluconate wipes market over the forecast period.

The COVID-19 pandemic has been a key driver for the global chlorhexidine gluconate wipes market due to the need for materials to eliminate microbial contamination in hospitals and other healthcare agencies. The growing prevalence of coronavirus is likely to drive the demand from the global chlorhexidine gluconate wipes market over the forecast period.

Competitive Leaderboard:

Leading players in the global chlorhexidine gluconate wipes market include Pal International, Lernapharm Inc., PDI Ltd., Carenow Medical Pvt. Ltd., GAMA Healthcare Ltd., Cardinal Health, 3M, and Becton Dickinson and Company.

In October 2018, 3M announced the launch of SoluPrep Film-Forming Sterile Surgical Solution, a 2% chlorhexidine gluconate and 70% isopropyl alcohol surgical skin prep that are used to help clinicians in the fight against surgical site infections.

In July 2017, Cardinal Health acquired Medtronic’s patient care, deep vein thrombosis, and nutritional insufficiency business (patient recovery business).

In May 2017, GAMA Healthcare Ltd acquired the Clinell division of its Australian distributor, AMCLA Pty Ltd, in Victoria. This investment demonstrates GAMA's continued commitment to infection prevention providing outstanding education, training, and clinical support to healthcare professionals across the world.

Segmentation:

The global chlorhexidine gluconate wipes market is segmented on the basis of product type, concentration, application, distribution channel, and region.

By product type, the global chlorhexidine gluconate wipes market is segmented into chlorhexidine gluconate bath wipes and chlorhexidine gluconate/alcohol-based wipes.

By concentration, the global chlorhexidine gluconate wipes market is segmented into 2% and 5%.

By application, the global chlorhexidine gluconate wipes market is segmented into surgical site infection, central line-associated bloodstream infection, catheter-associated urinary tract infections, and lens cleaners.

By distribution channel, the global chlorhexidine gluconate wipes market is segmented into hospital and retail pharmacies, and online platforms. The hospital and retail pharmacies segment dominates the global chlorhexidine gluconate wipes market and is likely to remain the major revenue generator over the forecast period. However, the online platforms segment has also shown rapid growth over the last few years and is likely to grow over the forecast period.

Regional Analysis:

The Americas are expected to dominate the global chlorhexidine gluconate wipes market size over the forecast period. Widespread awareness about surgical site infections and hospital-acquired infections in general in North America is the major driver for the chlorhexidine gluconate wipes market in the region. Growing government support to measures to reduce hospital-acquired infections is likely to be a major driver for the chlorhexidine gluconate wipes market in North America over the forecast period.

Europe is also a major regional market for chlorhexidine gluconate wipes due to the high healthcare expenditure in the region.

Asia Pacific is likely to be a growing regional market for chlorhexidine gluconate wipes over the forecast period due to the growing healthcare sector in the region and growing awareness about hospital-acquired infections in the region.

For more information visit at MarketResearchFuture